about
Expression of the human neuropeptide tyrosine Y1 receptorBiophysical methods to study ligand-receptor interactions of neuropeptide YNeuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.Neuropeptide Y and Y1-receptor agonists increase blood flow through arteriovenous anastomoses in rat tail.Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.Heterogeneous control of blood flow amongst different vascular beds.The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium.Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists.Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.Characterization of the inhibitory prostanoid receptors on human neutrophils.Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.Characterization of prostanoid receptors on rat neutrophils.Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.Endogenous NPY acting on the Y1 receptor accounts for the long-lasting part of the sympathetic contraction in guinea-pig vena cava: evidence using SR 120107A.Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.The murine Y1 receptor 5' upstream sequence directs cell-specific and developmentally regulated LacZ expression in transgenic mice CNS.Histamine-independent modulation of the neuropeptide Y-induced pressor response by alpha-trinositol in the pithed rat.Neuropeptide Y and its receptors in ventricular endocardial endothelial cells.Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules.Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin-induced diabetic rat
P2860
Q24320115-B4257D04-AE54-4027-98C5-1AAC77C55BB8Q28220437-BB06F09A-8F22-45FA-8DB5-9BD2D3239E6EQ31811904-C9B0BF5B-871E-44FC-BA6A-B5BFFC4D1DA0Q32056772-E9E2289C-4D59-4968-B074-1B7F758FCB9EQ33888019-4D5F2F6C-19AF-4C2D-8CEC-CE37E7E6C88CQ34116844-07B4DC3B-2FAD-4A04-9B50-912CEF5406EFQ35026223-FB20F360-401E-418E-8F7D-D5BAA7879C5BQ35872833-6FFF6EEE-E5C5-43F0-8061-5C7DC4155AC2Q35873194-71E65334-D278-4241-81CB-4F491A7E8685Q36606890-988CA3B1-E2C6-429D-97F9-8A4DB8641B55Q36814747-444599E1-CC5B-4C4E-8369-78026AE6EA70Q40614400-0AD73988-E3F8-4E8F-A71D-2D8D0907B194Q40706332-13220E52-BDB9-4175-B047-5CB00C8EDC8CQ41130900-66FF6DA7-4D97-40A0-8379-50A8F312BD2EQ41817173-4594C546-6185-4B21-B61D-1BB93E394C56Q41843644-B3C544CE-F71C-40EB-A3FE-548E4291F569Q42179884-66A84442-D617-4E56-8441-07431258C56EQ42186738-45EA5704-C1A7-4745-BEFD-02AA0CEB7A20Q42485703-0AA7982F-C0B3-4ABC-99B7-0E5FD6CE175FQ42581670-BBF9AB7B-014B-42A5-BA86-8C693333FA0CQ42701741-DE0556EF-47BB-475E-9AA9-B54F4BE51059Q42709811-7577E398-6022-4639-B793-D40DA6E33118Q43167254-AFFAA714-23F2-453F-8B0F-D0305E951475Q43189767-48B0825B-8809-49B8-B898-D04AD3626ADEQ44438360-61790733-056B-4DD6-B12E-EC171A599D30Q46308401-4CC7FE61-9EE1-47A8-85AC-89DC8946D9CAQ48278426-A989BDFC-430B-4E8C-9563-9BB57B56D0FEQ48368440-3CF2BB59-E87C-48C8-9CEA-857DD3ACC820Q51618007-1C33E537-9F17-476F-929B-73B36DF743C0Q51821037-775A4B3B-4706-4294-9DBA-F991CDD96B5DQ53579162-6166E313-7CC4-47A6-91C4-3D690F862936Q54359195-3D3A0E8C-6E08-4AC1-BB61-783369F44D2AQ57339341-63822888-C978-4554-84DF-389561A4A8A5
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Characterization of vascular neuropeptide Y receptors.
@en
Characterization of vascular neuropeptide Y receptors.
@nl
type
label
Characterization of vascular neuropeptide Y receptors.
@en
Characterization of vascular neuropeptide Y receptors.
@nl
prefLabel
Characterization of vascular neuropeptide Y receptors.
@en
Characterization of vascular neuropeptide Y receptors.
@nl
P2093
P2860
P1476
Characterization of vascular neuropeptide Y receptors.
@en
P2093
Grundemar L
Högestätt ED
Wahlestedt C
P2860
P356
10.1111/J.1476-5381.1992.TB14208.X
P407
P577
1992-01-01T00:00:00Z